ALYSSA JANOUSEK: Open Payments
NPI 1922767474 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 25 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 5 | $112 |
| ABBVIE INC. | 4 | $82 |
| Phathom Pharmaceuticals, Inc. | 6 | $58 |
| QOL Medical, LLC | 2 | $53 |
| Ardelyx, Inc. | 2 | $50 |
| Ipsen Biopharmaceuticals, Inc | 2 | $38 |
| Gilead Sciences, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
Products named: REZDIFFRA, VOQUEZNA, Sucraid, IBSRELA, IQIRVO, CREON, RINVOQ, ENTYVIO.
Industry payments across TX — which companies pay providers there.
